PO.BCS01.06 · 生物信息与计算
使用深度学习对肺癌全切片图像进行临床级质量控制和染色协调增强
Clinical-grade quality control and stain harmonization enhancement in whole-slide images of lung cancer using deep learning
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:在苏木精-伊红(H&E)全切片图像(WSI)上训练的深度学习模型日益支持肺癌的预后和治疗反应生物标志物。然而,其可靠性常因图像模糊、扫描仪和笔迹伪影以及切片间染色变异性而受损,这些因素掩盖组织形态并引入虚假的预测信号。为缓解这些问题,我们开发了一个全面、定量的WSI质量控制(QC)和染色协调流程,专门针对单一模式的肺腺癌,并评估了其对临床结局预测的下游影响。
方法:我们分析了来自Dartmouth肺腺癌队列的143张H&E WSI(20×,0.5μm/像素)。QC纳入了多个切片层面的指标,包括排除伪影的组织掩膜、使用≤600个以组织为中心的裁剪块的拉普拉斯方差量化局部模糊、缩略图衍生的亮度统计以及苏木精光密度中位数。仅当切片满足严格阈值时才予以保留:组织覆盖率≥40%、伪影分数≤1%、模糊组织分数≤5%、亮度140-210以及苏木精中位数0.10-0.35。在通过QC的切片中,一个自动化程序基于与亮度和苏木精指标中位数的接近程度选择一张队列代表性参考切片;其Macenko染色向量和第99百分位浓度参数用于协调。所有被接受的WSI均标准化至该参考。从标准化切片中,提取组织分数≥70%且伪影分数≤2%的256×256图块(步长256),以训练一个切片层面的二元结局模型。
结果:在143张WSI中,140张(97.9%)通过了QC;3张被排除。保留的切片中位分辨率为33,792×46,080像素。从128个通过QC的病例中,我们获得了215,220个可供分析的图块(每张切片中位数1,590个)。相比之下,一个更简单的基于Otsu的流程产生了249,073个图块;因此,QC感知的掩膜去除了13.6%的候选块——主要是低组织或富含伪影的区域——而没有减少肿瘤或基质覆盖。染色标准化的预览显示出高度一致的H&E外观。分类器性能从未进行QC/协调时的90.63%±9.36提高到实施后的95.32%±4.05。
结论:这一标准化的QC和染色协调框架有效地排除了低质量切片和富含伪影的区域,同时大幅提高了基于深度学习的肺腺癌临床结局预测的稳定性和准确性。通过减少技术混杂因素并强制执行染色一致性,该工作流程增强了WSI衍生生物标志物的稳健性、可重复性和转化就绪性,并支持计算病理学中的多机构协调工作。
查看英文原文 English abstract
Background: Deep learning models trained on hematoxylin-eosin (H&E) whole-slide images (WSIs) increasingly support prognostic and therapeutic-response biomarkers in lung cancer. However, their reliability is often compromised by image blur, scanner and pen artifacts, and inter-slide stain variability that obscure tissue morphology and introduce spurious predictive signals. To mitigate these issues, we developed a comprehensive, quantitative WSI quality-control (QC) and stain-harmonization pipeline tailored to single-pattern lung adenocarcinoma and assessed its downstream impact on clinical outcome prediction.
Methods: We analyzed 143 H&E WSIs (20×, 0.5 μm/pixel) from a Dartmouth lung adenocarcinoma cohort. QC incorporated multiple slide-level metrics, including tissue masks excluding artifacts, quantification of local blur using variance of the Laplacian across ≤600 tissue-centered crops, thumbnail-derived brightness statistics, and hematoxylin optical-density medians. Slides were retained only if they satisfied strict thresholds: tissue coverage ≥40%, artifact fraction ≤1%, blurry-tissue fraction ≤5%, brightness 140-210, and hematoxylin median 0.10-0.35. Among QC-cleared slides, an automated procedure selected a cohort-representative reference slide based on proximity to median brightness and hematoxylin metrics; its Macenko stain vectors and 99th-percentile concentration parameters were used for harmonization. All accepted WSIs were normalized to this reference. From normalized slides, 256×256 tiles (stride 256) with tissue fraction ≥70% and artifact fraction ≤2% were extracted to train a slide-level binary outcome model.
Results: Of 143 WSIs, 140 (97.9%) passed QC; three were excluded. Retained slides had a median resolution of 33,792 × 46,080 pixels. From 128 QC-passing cases, we obtained 215,220 analysis-ready tiles (median 1,590 per slide). By comparison, a simpler Otsu-based pipeline produced 249,073 tiles; thus, QC-aware masking removed 13.6% of candidates-primarily low-tissue or artifact-laden regions-without diminishing tumor or stromal coverage. Stain-normalized previews demonstrated highly consistent H&E appearance. Classifier performance improved from 90.63% ± 9.36 without QC/harmonization to 95.32% ± 4.05 following implementation.
Conclusions: This standardized QC and stain-harmonization framework effectively excludes low-quality slides and artifact-heavy regions while substantially improving the stability and accuracy of deep learning-based clinical outcome prediction in lung adenocarcinoma. By reducing technical confounders and enforcing stain consistency, the workflow enhances the robustness, reproducibility, and translational readiness of WSI-derived biomarkers and supports multi-institutional harmonization efforts in computational pathology.
利益披露 Disclosure
M. Hosseini, None..
R. Choudhary, None..
H. Siezen, None..
S. J. Carello, None..
O. El-Zammar, None..
B. Rodd, None.